Medesis Pharma (France) Probability of Future Stock Price Finishing Over 19.09
| ALMDP Stock | EUR 0.35 0.01 2.94% |
Medesis |
Medesis Pharma Target Price Odds to finish over 19.09
The tendency of Medesis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 19.09 or more in 90 days |
| 0.35 | 90 days | 19.09 | close to zero percent |
Based on a normal probability distribution, the odds of Medesis Pharma to move over € 19.09 or more in 90 days from now is close to zero percent (This Medesis Pharma SA probability density function shows the probability of Medesis Stock to fall within a particular range of prices over 90 days) . Probability of Medesis Pharma SA price to stay between its current price of € 0.35 and € 19.09 at the end of the 90-day period is about 83.42 .
Assuming the 90 days trading horizon Medesis Pharma SA has a beta of -1.26. This suggests as returns on its benchmark rise, returns on holding Medesis Pharma SA are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Medesis Pharma is expected to outperform its benchmark. Additionally Medesis Pharma SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Medesis Pharma Price Density |
| Price |
Predictive Modules for Medesis Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medesis Pharma SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Medesis Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Medesis Pharma is not an exception. The market had few large corrections towards the Medesis Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medesis Pharma SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medesis Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.32 | |
β | Beta against Dow Jones | -1.26 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | -0.09 |
Medesis Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medesis Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medesis Pharma SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Medesis Pharma SA generated a negative expected return over the last 90 days | |
| Medesis Pharma SA has high historical volatility and very poor performance | |
| Medesis Pharma SA has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 95.73 K. Net Loss for the year was (2.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| About 17.0% of the company shares are held by company insiders |
Medesis Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medesis Stock often depends not only on the future outlook of the current and potential Medesis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medesis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.4 M | |
| Cash And Short Term Investments | 2.9 M |
Medesis Pharma Technical Analysis
Medesis Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Medesis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medesis Pharma SA. In general, you should focus on analyzing Medesis Stock price patterns and their correlations with different microeconomic environments and drivers.
Medesis Pharma Predictive Forecast Models
Medesis Pharma's time-series forecasting models is one of many Medesis Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medesis Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Medesis Pharma SA
Checking the ongoing alerts about Medesis Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medesis Pharma SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Medesis Pharma SA generated a negative expected return over the last 90 days | |
| Medesis Pharma SA has high historical volatility and very poor performance | |
| Medesis Pharma SA has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 95.73 K. Net Loss for the year was (2.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| About 17.0% of the company shares are held by company insiders |
Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.